LIBERVANT Drug Patent Profile
✉ Email this page to a colleague
When do Libervant patents expire, and when can generic versions of Libervant launch?
Libervant is a drug marketed by Aquestive and is included in one NDA.
The generic ingredient in LIBERVANT is diazepam. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Libervant
A generic version of LIBERVANT was approved as diazepam by MYLAN on September 4th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIBERVANT?
- What are the global sales for LIBERVANT?
- What is Average Wholesale Price for LIBERVANT?
Summary for LIBERVANT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Patent Applications: | 1,178 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in LIBERVANT? | LIBERVANT excipients list |
| DailyMed Link: | LIBERVANT at DailyMed |
Pharmacology for LIBERVANT
| Drug Class | Benzodiazepine |
US Patents and Regulatory Information for LIBERVANT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-001 | Apr 26, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-004 | Apr 26, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-002 | Apr 26, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aquestive | LIBERVANT | diazepam | FILM;BUCCAL | 218623-003 | Apr 26, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
